CirQuest in NEJM

March 19, 2019

Our Navigators are pleased to announce the publication of "Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers" in the latest edition of the New England Journal of Medicine. Our founder and CEO, Dr. Lisa K. Jennings, worked with trailblazing partners from the Brigham and Women’s Hospital Heart and Vascular Center, Harvard Medical School, Thomas Jefferson University, the Thrombosis and Atherosclerosis Research Institute, and PhaseBio Pharmaceuticals to co-author this fascinating study. Visit NEJM to read the publication.  

 

 

Share on Twitter
Please reload

Recent Posts

October 25, 2019

March 23, 2019

March 19, 2019

Please reload

Archive
Please reload

Search By Tags

I'm busy working on my blog posts. Watch this space!

Please reload

Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Google+ Basic Square